Publication
Title
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization : a new challenge?
Author
Abstract
Arterial calcification has been found to coexist with bone loss. Bisphosphonates, used as standard therapy for osteoporosis, inhibit experimentally induced vascular calcification, offering perspectives for the treatment of vascular calcification in renal failure patients. However, Lomashvili et al. report that the doses of etidronate and pamidronate that are effective in attenuating aortic calcification also decrease bone formation and mineralization in uremic rats, limiting their therapeutic use as anticalcifying agents.
Language
English
Source (journal)
Kidney international / International Society of Nephrology. - New York, N.Y., 1972, currens
Publication
New York, N.Y. : 2009
ISSN
0085-2538 [print]
1523-1755 [online]
Volume/pages
75:6(2009), p. 580-582
ISI
000263723200004
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 04.11.2014
Last edited 12.06.2017
To cite this reference